Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 1, 2020
Poly(2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicityDuhyeong Hwang, Taylor Dismuke, Andrey Tikunov, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 10, 2025
Extracellular vesicle as therapeutic agents in anti-aging: Mechanistic insights and future potentialHyejoo Yoon, Junyeong Jo, Hyesun Hyun, et al.Biorxiv : the Preprint Server for Biology|April 17, 2026
Nanoparticle-delivered resiquimod induces brain tumor regression in medulloblastoma and diffuse midline glioma models by interrupting paracrine growth support and activating myeloid immune signaling and phagocytosisLeon McSwain, Kyongtea Kim, Duhyeong Hwang, et al.Nano Today|July 24, 2023
High-Dose Paclitaxel and its Combination with CSF1R Inhibitor in Polymeric Micelles for Chemoimmunotherapy of Triple Negative Breast CancerChaemin Lim, Duhyeong Hwang, Mostafa Yazdimamaghani, et al.Biomaterials|October 11, 2021
Bioequivalence assessment of high-capacity polymeric micelle nanoformulation of paclitaxel and Abraxane® in rodent and non-human primate models using a stable isotope tracer assayDuhyeong Hwang, Natasha Vinod, Sarah L Skoczen, et al.Biorxiv : the Preprint Server for Biology|July 3, 2023
Combination of Polymeric Micelle Formulation of TGFβ Receptor Inhibitors and Paclitaxel Produce Consistent Response Across Different Mouse Models of TNBCNatasha Vinod, Duhyeong Hwang, Sloane Christian Fussell, et al.Bioengineering & Translational Medicine|November 18, 2024
Combination of polymeric micelle formulation of TGFβ receptor inhibitors and paclitaxel produces consistent response across different mouse models of Triple-negative breast cancerNatasha Vinod, Duhyeong Hwang, Sloane Christian Fussell, et al.Nature Communications|December 22, 2019
scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapyJennifer Karin Ocasio, Benjamin Babcock, Daniel Malawsky, et al.Nature Communications|February 5, 2025
Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179Yuchen Li, Chaemin Lim, Taylor Dismuke, et al.Research Square|June 19, 2023
Preventing recurrence in Sonic Hedgehog Subgroup Medulloblastoma using the OLIG2 inhibitor CT-179Yuchen Li, Chaemin Lim, Taylor Dismuke, et al.Pageof 3